Skip to content

Clinical trials

Phase 3 Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 3 Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20063
20071
20083
20092
20101
20111
20141
20151
20161
20183
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting3
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
AbbVie2
NovoCure Ltd.2
AstraZeneca1
Bristol-Myers Squibb1
Canadian Cancer Trials Group1
CarThera1
Celldex Therapeutics1
EMD Serono1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma26
Brain Neoplasms11
Astrocytoma5
Neoplasms5
Glioma4
Gliosarcoma4
Central Nervous System Neoplasms2
Adenocarcinoma1
Diffuse Intrinsic Pontine Glioma1
Neoplasms, Neuroepithelial1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.